Related Experiment Videos
Retroperitoneal inflammatory myofibroblastic tumor.
Suresh V S Attili1, C Rama Chandra, Dadhich K Hemant
1Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India. sureshattili@yahoo.com
World Journal of Surgical Oncology
|October 11, 2005
Summary
Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm. Surgical resection is the primary treatment for this condition, which can present as a retroperitoneal mass.
Area of Science:
- Oncology
- Pathology
Background:
- Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm of uncertain etiology.
- IMT is characterized by spindle cells (myofibroblasts) and an inflammatory infiltrate.
- These tumors can occur at various anatomical sites.
Purpose of the Study:
- To present a case of retroperitoneal inflammatory myofibroblastic tumor.
- To highlight the diagnostic and management considerations for IMT.
Main Methods:
- A case report of a 46-year-old female patient.
- Clinical presentation included flank pain, abdominal mass, and hematuria.
- Diagnosis was confirmed post-operatively after initial suspicion of renal cell carcinoma.
Main Results:
- The patient was diagnosed with a retroperitoneal IMT.
- Complete surgical resection was performed as the management strategy.
Conclusions:
- Inflammatory myofibroblastic tumor is a rare entity with unpredictable biological potential.
- Complete surgical resection is the established primary treatment for IMT.